AR-14034

· Alcon Research

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AR-14034, covering 2026-01-06 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD) [Phase 1, Phase 2]